BEIJING, Jan. 9, 2024
/PRNewswire/ -- Concord Medical Services Holdings Limited
("Concord Medical" or the "Company") (NYSE: CCM), a healthcare
provider specialized in cancer treatment, research, education and
prevention in China, today
announced the listing of a minority stake of 39,420,200 H shares in
Concord Healthcare Group Co., Ltd. ("Concord Healthcare"), its
subsidiary, at an initial public offer price of HK$14.28 per H share on the Main Board of The
Stock Exchange of Hong Kong Limited (the "HKSE") under the stock
code 2453.HK. Concord Healthcare's H shares began to trade on the
HKSE on January 9, 2024. The Company
previously announced the submission of an application proof to list
a minority stake in Concord Healthcare on the HKSE on June 1, 2022.
The gross proceeds from the initial public offering of Concord
Healthcare on the HKSE are HK$562.9
million (approximately US$72.2
million). Concord Healthcare intends to apply approximately
59.4% of the net proceeds for repaying part of its interest-bearing
bank borrowings, approximately 30.6% of the net proceeds for
financing the construction of Shanghai Concord Cancer Center, and
approximately 10.0% of the net proceeds for working capital and
other general corporate purposes.
The information related to the listing of Concord Healthcare's H
shares on the HKSE is accessible through the HKSE's website at
www.hkexnews.hk. This announcement is not intended to, and
does not, constitute an offer to sell or a solicitation of an offer
to purchase any securities, in the United
States or elsewhere, and it is not intended to, and does
not, constitute an offer, solicitation or sale of any securities in
any state or jurisdiction in which such an offer, solicitation or
sale would be unlawful.
About Concord Medical
Concord Medical Services Holdings Limited is a healthcare
provider featuring a full cycle of premium oncology services
including cancer diagnosis, treatment, education and prevention.
The Company focuses on providing multidisciplinary cancer care in
all aspects of oncology healthcare services in its cancer hospitals
and equipping them with technologically advanced equipment such as
the state-of-the-art proton therapy system. The Company is striving
to improve the quality and accessibility of cancer care through its
network of self-owned cancer hospitals and clinics as well as
partnered hospitals across China.
For more information, please see http://ir.ccm.cn.
About Concord Healthcare
Concord Healthcare is an oncology healthcare provider in
China. Concord Healthcare serves
both cancer patients through self-owned medical institutions and
third-party medical institutions through medical equipment,
software and related services. In its self-owned medical
institutions, Concord Healthcare provides a full spectrum of
oncology healthcare services to cancer patients across the entire
care continuum, leveraging its multidisciplinary team specialists
and diagnosis and treatment capabilities featuring precision
radiation therapy. Through its medical equipment, software and
related services, Concord Healthcare serves a widespread network of
enterprise customers, primarily hospitals, with integrated
oncology-related services, including primarily sales and installing
of medical equipment and software, management and technical
support, and operating lease.
Safe Harbor Statement
This announcement contains forward-looking statements. These
forward-looking statements can be identified by words or phrases
such as "will," "expects," "anticipates," "future," "intends,"
"plans," "believes," "estimates" and similar expressions.
Forward-looking statements are inherently subject to uncertainties
and contingencies beyond the Company's control and based upon
premises with respect to future business decisions, which are
subject to change. A number of important factors could cause actual
results to differ materially from those contained in any
forward-looking statement. The Company does not undertake any
obligation to update any forward-looking statement, except as
required under applicable law.
View original
content:https://www.prnewswire.com/news-releases/concord-medical-announces-listing-of-its-subsidiary-on-the-stock-exchange-of-hong-kong-limited-302029435.html
SOURCE Concord Medical Services Holdings Limited